483
Daito Pharmaceutical Co., Ltd.Daito Pharmaceutical Co., Ltd. – FDA 483, Sep 16, 2022
Record Details
An FDA inspection of Daito Pharmaceutical Co., Ltd. in Toyama City, Japan, revealed two observations related to quality system deficiencies. The firm failed to adequately investigate unexplained discrepancies and ensure proper follow-up actions. Additionally, the quality control unit did not fully adhere to its responsibilities and procedures, leading to premature closure of deviation reports and approval of change controls before completion.
View Company Profile
ID · b83bda10-2781-44c9-afce-1dd89e917c4a
Other documents for Daito Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.